|本期目录/Table of Contents|

[1]廖诗晗,赵秀兰,张艳辉,等.LCMT1在肝癌中的表达和预后的意义[J].天津医科大学学报,2019,25(03):246-250.
 LIAO Shi-han,ZHAO Xiu-lan,ZHANG Yan-hui,et al.The expression and prognostic significance of LCMT1 in hepatocellular carcinoma[J].Journal of Tianjin Medical University,2019,25(03):246-250.
点击复制

LCMT1在肝癌中的表达和预后的意义(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25卷
期数:
2019年03期
页码:
246-250
栏目:
临床医学
出版日期:
2019-05-20

文章信息/Info

Title:
The expression and prognostic significance of LCMT1 in hepatocellular carcinoma
文章编号:
1006-8147(2019)03-0246-05
作者:
廖诗晗1赵秀兰1张艳辉2刘铁菊1董学易1车 娜1梁晓辉1李逸仙1
(1.天津医科大学基础医学院病理学教研室,天津 300070;2.天津医科大学肿瘤医院病理科,天津 300060)
Author(s):
LIAO Shi-han1 ZHAO Xiu-lan1 ZHANG Yan-hui2 LIU Tie-ju1 DONG Xue-yi1 CHE Na1 LIANG Xiao-hui1 LI Yi-xian1
(1.Department of Pathology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070China;2.Department of Pathology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin 300060, China)
关键词:
LCMT1GEPIA数据库MMP2MAPK3肝癌
Keywords:
LCMT1GEPIA databaseMMP2MAPK3hepatocellular carcinoma
分类号:
R365
DOI:
-
文献标志码:
A
摘要:
目的:探讨亮氨酸羧基甲基转移酶1(LCMT1)在肝癌中的表达和预后的意义。方法:通过收集网络数据库GEPIA中有关信息进行LCMT1表达情况的分析、相关性分析和生存分析,然后通过免疫组化染色进一步分析LCMT1在肝癌中的表达和预后。结果:LCMT1在肾上腺皮质癌、弥漫性大B细胞淋巴瘤、肝癌和胸腺瘤中的表达和正常组织的表达相比具有统计学意义(P<0.05)。LCMT1在肝癌中高表达,且高表达的患者生存时间短,更容易发生转移。LCMT1和金属蛋白酶2(MMP2)之间的相关系数为0.324(P<0.05)。LCMT1和丝裂原活化蛋白激酶3(MAPK3)存在正相关关系且相关系数为0.76(P<0.05)。结论:LCMT1在肝癌中高表达,且高表达与患者的不良预后有关,LCMT1可能通过激活MAPK3的磷酸化而促进肝癌的发生。
Abstract:
Objective: To investigate the expression and prognostic significance of LCMT1 in hepatocellular carcinoma. Methods: Through collecting relevant information in GEPIA network database, the expression of LCMT1 was analyzed; correlation analysis and survival analysis were carried out. Results: The expression of LCMT1 in adrenal cortical carcinoma, diffuse large B-cell lymphoma, hepatocellular carcinoma and thymoma was significantly higher than that in normal tissues. LCMT1 was highly expressed in hepatocellular carcinoma, and the survival time of patients with high expression of LCMT1 was short, as well as the metastasis. The correlation coefficient between LCMT1 and MMP2 was 0.324. There was a positive correlation between LCMT1 and MAPK3 and the correlation coefficient was 0.76. Conclusion: LCMT1 and MAPK3 are highly expressed in hepatocellular carcinoma, and their high expressions are associated with poor prognosis. LCMT1 is highly expressed in hepatocellular carcinoma and is associated with poor prognosis. LCMT1 may promote the occurrence of hepatocellular carcinoma by activating the phosphorylation of MAPK3.

参考文献/References:

[1] Wu M, Liu Z, Zhang A, et al. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis[J]. Medicine (Baltimore), 2019, 98(5): e14287
[2] Palanichamy K, Kanji S, Gordon N, et al. NNMT silencing activates tumor suppressor PP2A, inactivates oncogenic STKs, and inhibits tumor forming ability[J]. Clin Cancer Res, 2017, 23(9): 2325
[3] Creighton M T, Kolton A, Kataya A, et al. Methylation of protein phosphatase 2A-influence of regulators and environmental stress factors[J]. Plant Cell Environ, 2017, 40(10): 2347
[4] Sontag J M, Wasek B, Taleski G, et al. Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase(MTHFR) deficient mice[J]. Front Aging Neurosci, 2014, 6: 214
[5] Sontag J M, Sontag E. Protein phosphatase 2A dysfunction in Alzheimer’s disease[J]. Front Mol Neurosci, 2014, 7:16
[6] Boland P, Wu J. Systemic therapy for hepatocellular carcinoma: beyond sorafenib[J]. Chin Clin Oncol, 2018, 7(5): 50
[7] Harris W P, Wong K M, Saha S, et al. Biomarker-driven and molecular targeted therapies for hepatobiliary cancers[J]. Semin Oncol,2018, 45(3):116
[8] Kim D H, Cho E, Cho S B, et al. Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell): A case report and literature review[J]. Medicine (Baltimore),2018, 97(42): e12866
[9] Xia X, Gholkar A, Senese S, et al. A LCMT1-PME-1 methylation equilibrium controls mitotic spindle size[J]. Cell Cycle, 2015, 14(12):1938
[10] Jiang Y, Zhang C, Ma J, et al. Expression of matrix Metalloproteinases-2 and aquaporin-1 in corneoscleral junction after angle-closure in rabbits[J]. BMC Ophthalmol, 2019, 19(1): 43
[11] Qu L, Jiao Y, Jiang Z, et al. Effects of acidification pretreatment for respiratory acidosis on the expression of matrix metalloproteinase-9 in rat lung tissues following ischemia/reperfusion[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2018, 43(11):1177
[12] Rahajeng R. The increased of MMP-9 and MMP-2 with the decreased of TIMP-1 on the uterosacral ligament after childbirth[J]. Pan Afr Med J, 2018, 30: 283
[13] Chu D, Tan J, Xie S, et al. GSK-3β is Dephosphorylated by PP2A in a Leu309 methylation-independent manner[J]. J Alzheimers Dis,2016, 49(2): 365
[14] Lee J A, Wang Z, Sambo D, et al. Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis[J]. J Biol Chem, 2018, 293(25): 9636
[15] Fan H Y, Liu Z, Shimada M, et al. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility[J]. Science, 2009, 324(5929): 938
[16] Tsubaki M. MET/ERK and MET/JNK pathway activation is involved in BCR-ABL inhibitor-resistance in chronic myeloid leukemia[J]. Yakugaku Zasshi, 2018, 138(12):1461
[17] Yang W, Cai J, Zhang H, et al. Effects of lidocaine and ropivacaine on gastric cancer cells through down-regulation of ERK1/2 phosphorylation in vitro[J]. Anticancer Res, 2018, 38(12): 6729
[18] Escobar S, Fong G M, Winnischofer S, et al. Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y[J]. Chem Biol Interact, 2019, 299: 77
[19] Hein A L, Seshacharyulu P, Rachagani S, et al. PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling[J]. Cancer Res, 2016, 76(8): 2243

相似文献/References:

[1]彭华红,肖龙飞,王林,等.ARL4C在睾丸生殖细胞肿瘤中的表达及临床意义[J].天津医科大学学报,2020,26(03):238.
 PENG Hua-hong,XIAO Long-fei,WANG Lin,et al.Expression and clinical significance of ARL4C in testicular germ cell tumors[J].Journal of Tianjin Medical University,2020,26(03):238.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金面上项目(81572872)
作者简介 廖诗晗(1992-),女,硕士在读,研究方向:病理学;通信作者:赵秀兰,E-mail:xiulanzhao@aliyun.com。
更新日期/Last Update: 2019-07-03